title: Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma.
authors.forename: Shih-Hung
authors.initials: SH
authors.lastname: Yang
authors.forename: Long-Wei
authors.initials: LW
authors.lastname: Lin
authors.forename: Yu-Jen
authors.initials: YJ
authors.lastname: Fang
authors.forename: Ann-Lii
authors.initials: AL
authors.lastname: Cheng
authors.forename: Sung-Hsin
authors.initials: SH
authors.lastname: Kuo
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D016731:Erythema Infectiosum / Q000150:complications* / Q000209:etiology* / Q000473:pathology; D005260:Female; D006505:Hepatitis / Q000209:etiology* / Q000473:pathology / Q000821:virology*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D016732:Parvovirus B19, Human / Q000472:pathogenicity*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab